NASDAQ:ABSI

Absci - ABSI Stock Forecast, Price & News

$3.36

-0.05 (-1.47%)

(As of 02/7/2023 12:00 AM ET)

Add

Compare

Today's Range: $3.21
▼
$3.44
50-Day Range: $2.00
▼
$3.41
52-Week Range: $1.94
▼
$9.68

Volume: 702,816 shs
Average Volume: 481,029 shs
Market Capitalization: $310.45 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $10.67

Institutional Ownership

Absci MarketRank™ Forecast

Analyst Rating: Moderate Buy
2.60 Rating Score
Upside/Downside: 217.5% Upside
$10.67 Price Target
Short Interest: Bearish
7.40% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: N/A
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($1.13) to ($0.95) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.03 out of 5 stars

Medical Sector

529th out of 1,029 stocks

Commercial Physical Research Industry

10th out of 16 stocks

3.3

Analyst's Opinion

Consensus Rating
Absci has received a consensus rating of Buy. The company's average rating score is 2.60, and is based on 4 buy ratings, no hold ratings, and 1 sell rating.
Price Target Upside/Downside
According to analysts' consensus price target of $10.67, Absci has a forecasted upside of 217.5% from its current price of $3.36.
Amount of Analyst Coverage
Absci has received no research coverage in the past 90 days.

1.0

Short Interest

Percentage of Shares Shorted
7.40% of the float of Absci has been sold short.
Short Interest Ratio / Days to Cover
Absci has a short interest ratio ("days to cover") of 11.1, which indicates bearish sentiment.
Change versus previous month
Short interest in Absci has recently decreased by 4.45%, indicating that investor sentiment is improving.

0.0

Dividend Strength

Dividend Yield
Absci does not currently pay a dividend.
Dividend Growth
Absci does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for ABSI.

3.2

News and Social Media Coverage

News Sentiment
Absci has a news sentiment score of 0.69. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.47 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 1 news article for Absci this week, compared to 2 articles on an average week.
Search Interest
18 people have searched for ABSI on MarketBeat in the last 30 days. This is an increase of 38% compared to the previous 30 days.
MarketBeat Follows
7 people have added Absci to their MarketBeat watchlist in the last 30 days. This is an increase of 600% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Absci insiders have not sold or bought any company stock.
Percentage Held by Insiders
19.39% of the stock of Absci is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
47.59% of the stock of Absci is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.3

Earnings and Valuation

Earnings Growth
Earnings for Absci are expected to grow in the coming year, from ($1.13) to ($0.95) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Absci is -2.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Absci is -2.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Absci has a P/B Ratio of 0.85. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Absci (NASDAQ:ABSI) Stock

Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.

Receive ABSI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Absci and its competitors with MarketBeat's FREE daily newsletter.

ABSI Stock News Headlines

January 10, 2023 | finance.yahoo.com

Absci First to Create and Validate De Novo Antibodies with Zero-Shot Generative AI

December 29, 2022 | finance.yahoo.com

Absci (NASDAQ:ABSI) shareholders have endured a 76% loss from investing in the stock a year ago

February 7, 2023 | Wall Street Watch Dogs (Ad)

The #1 Energy Stock to Buy

The next major energy revolution is unfolding right now. And it could hand early investors as much as 46,700% gains…

December 28, 2022 | finance.yahoo.com

Absci to Participate in the 41st Annual J.P. Morgan Healthcare Conference

November 23, 2022 | finance.yahoo.com

Absci to Participate in the Berenberg Discover AI Seminar

November 17, 2022 | finance.yahoo.com

Absci to Participate in the Piper Sandler Healthcare Conference

November 9, 2022 | finance.yahoo.com

Absci Reports Third Quarter 2022 Financial Results

November 9, 2022 | finance.yahoo.com

Absci Corporation (ABSI) Reports Q3 Loss, Tops Revenue Estimates

February 7, 2023 | Wall Street Watch Dogs (Ad)

The #1 Energy Stock to Buy

The next major energy revolution is unfolding right now. And it could hand early investors as much as 46,700% gains…

November 2, 2022 | finance.yahoo.com

Absci Welcomes Meta Senior Executive to Board of Directors

November 2, 2022 | finance.yahoo.com

Absci to Participate in the Stifel Healthcare Conference

October 26, 2022 | finance.yahoo.com

Absci to Participate in the 31st Annual Credit Suisse Healthcare Conference

October 19, 2022 | nasdaq.com

Institutional investors own a significant stake of 29% in Absci Corporation (NASDAQ:ABSI)

October 4, 2022 | bizjournals.com

Absci hires Adreas Busch to lead R&D - Portland Business Journal - The Business Journals

October 4, 2022 | globenewswire.com

Absci Appoints Veteran Pharma Executive Andreas Busch, PhD as Chief Innovation Officer - GlobeNewswire

October 4, 2022 | finance.yahoo.com

Absci Appoints Veteran Pharma Executive Andreas Busch, PhD as Chief Innovation Officer

September 30, 2022 | bloomberg.com

Credit Suisse Rehires Health-Care Investment Banker Nikhil Goel - Bloomberg

September 28, 2022 | finance.yahoo.com

Institutional owners may consider drastic measures as Absci Corporation's (NASDAQ:ABSI) recent US$46m drop adds to long-term losses

September 26, 2022 | nasdaq.com

Analysts Expect 41% Gains Ahead For VBK - Nasdaq

September 13, 2022 | bizjournals.com

Oregon and Washington stock prices plummet - Portland Business Journal - The Business Journals

September 3, 2022 | benzinga.com

(ABSI) – Absci to Participate in the Morgan Stanley Global Healthcare Conference - Benzinga

August 31, 2022 | markets.businessinsider.com

Pre-market Movers: MGAM, SNTG, FREY, BBBY, ABSI…

August 30, 2022 | nasdaq.com

Pre-market Movers: MGAM, SNTG, FREY, BBBY, ABSI… - Nasdaq

August 24, 2022 | finance.yahoo.com

Absci to Participate at the Inaugural Gilmartin Group Emerging Growth Company Showcase

August 23, 2022 | nasdaq.com

Implied VBK Analyst Target Price: $282 - Nasdaq

August 20, 2022 | nasdaq.com

Shareholders in Absci (NASDAQ:ABSI) have lost 79%, as stock drops 12% this past week - Nasdaq

August 16, 2022 | bizjournals.com

OVF hires OCF director to lead fundraising of $50M-$100M target - The Business Journals

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive ABSI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Absci and its competitors with MarketBeat's FREE daily newsletter.

ABSI Company Calendar

Last Earnings: 11/09/2022
Today: 2/07/2023
Next Earnings (Estimated): 3/28/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Commercial physical research
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:ABSI
CUSIP: N/A
CIK: 1672688
Web: www.absci.com
Phone: 360-949-1041
Fax: N/A
Employees: 211
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $10.67
High Stock Price Forecast: $14.00
Low Stock Price Forecast: $8.00
Forecasted Upside/Downside: +217.5%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.60
Research Coverage: 5 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($1.23)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-100,960,000.00
Net Margins: -1,960.28%
Pretax Margin: -1,979.12%
Return on Equity: -33.62%
Return on Assets: -28.97%

Debt

Debt-to-Equity Ratio: 0.03
Current Ratio: 6.71
Quick Ratio: 6.71

Sales & Book Value

Annual Sales: $5.64 million
Price / Sales: 55.02
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $3.95 per share
Price / Book: 0.85

Miscellaneous

Outstanding Shares: 92,395,000
Free Float: 74,480,000
Market Cap: $310.45 million
Optionable: Not Optionable
Beta: 1.18

Key Executives

Mr. Sean McClain (Age 32)
Founder, CEO, Pres & Director
Comp: $1.02M

Dr. Sarah Korman J.D. (Age 44)
Ph.D., Chief Legal Officer & Corp. Sec.
Comp: $591.47k

Mr. Gregory T. Schiffman CPA (Age 66)
CPA, MBA, Chief Financial Officer

Todd Bedrick CPA
Sr. VP & Chief Accounting Officer

Mr. Jack Gold
Chief Marketing Officer

Melissa Patterson Ph.D.
Chief of Staff

Ms. Denise Dettore
Chief People Officer

Dr. Andreas Busch Ph.D. (Age 60)
Chief Innovation Officer

Jonathan Eads M.S.
Sr. VP of Informatics

Thomas Wrona J.D.
Ph.D., Sr. VP of Intellectual Property

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

ABSI Stock - Frequently Asked Questions

Should I buy or sell Absci stock right now?: 5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Absci in the last year. There are currently 1 sell rating and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ABSI shares.
View ABSI analyst ratings or view top-rated stocks.
What is Absci's stock price forecast for 2023?: 5 equities research analysts have issued 1-year target prices for Absci's shares. Their ABSI share price forecasts range from $8.00 to $14.00. On average, they predict the company's share price to reach $10.67 in the next twelve months. This suggests a possible upside of 225.2% from the stock's current price.
View analysts price targets for ABSI or view top-rated stocks among Wall Street analysts.
How have ABSI shares performed in 2023?: Absci's stock was trading at $2.10 at the beginning of the year. Since then, ABSI shares have increased by 56.2% and is now trading at $3.28.
View the best growth stocks for 2023 here.
When is Absci's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, March 28th 2023.
View our ABSI earnings forecast.
How were Absci's earnings last quarter?: Absci Co. (NASDAQ:ABSI) released its quarterly earnings data on Wednesday, November, 9th. The company reported ($0.30) earnings per share for the quarter, missing the consensus estimate of ($0.27) by $0.03. The company earned $2.37 million during the quarter, compared to analyst estimates of $1.79 million. Absci had a negative trailing twelve-month return on equity of 33.62% and a negative net margin of 1,960.28%.
When did Absci IPO?: (ABSI) raised $200 million in an initial public offering on Thursday, July 22nd 2021. The company issued 12,500,000 shares at $15.00-$17.00 per share.

What is Absci's stock symbol?: Absci trades on the NASDAQ under the ticker symbol "ABSI."
Who are Absci's major shareholders?: Absci's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Wealth Alliance Advisory Group LLC (0.03%), SG Americas Securities LLC (0.02%), Ronald Blue Trust Inc. (0.02%), D Orazio & Associates Inc. (0.02%), Simplex Trading LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Karen K Mcginnis, Sarah Korman, Sean Mcclain and Todd Bedrick.
View institutional ownership trends.
How do I buy shares of Absci?: Shares of ABSI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Absci's stock price today?: One share of ABSI stock can currently be purchased for approximately $3.28.
How much money does Absci make?: Absci (NASDAQ:ABSI) has a market capitalization of $303.04 million and generates $4.78 million in revenue each year. The company earns $-100,960,000.00 in net income (profit) each year or ($1.23) on an earnings per share basis.
How many employees does Absci have?: The company employs 211 workers across the globe.
How can I contact Absci?: The official website for the company is www.absci.com. The company can be reached via phone at 360-949-1041 or via email at investors@absci.com.

This page (NASDAQ:ABSI) was last updated on 2/7/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Absci - ABSI Stock Forecast, Price & News

Absci MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Absci (NASDAQ:ABSI) Stock

ABSI Stock News Headlines

ABSI Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders & Institutions

ABSI Stock - Frequently Asked Questions

Overall MarketRank^™